Category: Becton Dickinson & Co.
Becton Dickinson's $12.2 billion bid for device maker CareFusion clears the required waiting period under U.S. anti-trust regulations.
Here's a look at some of the top legal news stories for medical device companies this week: BD owes $340m to Retractable Technologies in anti-trust case; Feds indict Vascular Solutions, CEO over Vari-Lase; Federal jury begins deliberations in Boston Scientific mesh trial; Boston Scientific ordered to pay $26.7 million over mesh devices; Judge dismisses 76 Ethicon pelvic mesh lawsuits in Texas
A federal judge orders Becton, Dickinson & Co. to pay $340 million to Retractable Technologies for BD's claim that it had the 'world's sharpest needle.'
Sales and earnings rise during the fiscal 1st quarter for CareFusion as it prepares to be absorbed by Becton, Dickinson & Co.
CareFusion (NYSE:CFN) ended its last fiscal quarter as a public company on a strong note, posting earnings growth of 2.8% on a top-line gain of 11.1%.
Becton, Dickinson & Co. beats Wall Street's forecast with its fiscal 2015 sales and earnings, sending share prices up in pre-market training today.
The U.S. Patent & Trademark Office's patent trial board rules in favor of Becton Dickinson in a case involving a catheter-assembly patent held by One StockDuq Holdings.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: JNJ continues to pay hefty integration charges on Synthes deal; Stryker: Mako sales not as strong as we hoped; ConvaTec owners appoint banks to explore sale: sources; BD buys Irish next-gen sequencing startup GenCell Biosystems; Valeant says may raise Allergan bid; beats on profit
, Becton Dickinson & Co.
, DePuy Synthes
, GenCell Biosystems
, Johnson & Johnson
, Kimberly-Clark Worldwide Inc.
, MAKO Surgical Corp.
, Stryker Corp.
, Valeant Pharmaceuticals
, 3M Corp.
, Allergan Inc.